This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2007 Dec;16(12):1313-4; author reply 1314-6.

doi: 10.1002/pds.1498.

Studies of diabetes, thiazolidinediones, and coronary heart disease

Alexander M Walker, Andrew T McAfee, Carol Koro

PMID: 18041104
DOI: 10.1002/pds.1498

Comment

Studies of diabetes, thiazolidinediones, and coronary heart disease

Alexander M Walker et al. Pharmacoepidemiol Drug Saf. 2007 Dec.

. 2007 Dec;16(12):1313-4; author reply 1314-6.

doi: 10.1002/pds.1498.

Authors

Alexander M Walker, Andrew T McAfee, Carol Koro

PMID: 18041104
DOI: 10.1002/pds.1498

No abstract available

PubMed Disclaimer

Comment on

A comparison of pioglitazone and rosiglitazone for hospitalization for acute myocardial infarction in type 2 diabetes.
Gerrits CM, Bhattacharya M, Manthena S, Baran R, Perez A, Kupfer S. Gerrits CM, et al. Pharmacoepidemiol Drug Saf. 2007 Oct;16(10):1065-71. doi: 10.1002/pds.1470. Pharmacoepidemiol Drug Saf. 2007. PMID: 17674425

Similar articles

Diabetes drug safety update: Avandia and your heart.
[No authors listed] [No authors listed] Johns Hopkins Med Lett Health After 50. 2010 Jun;22(4):1-2, 7. Johns Hopkins Med Lett Health After 50. 2010. PMID: 20572316 No abstract available.
Thiazolidinediones, deadly sins, surrogates, and elephants.
Cleland JG, Atkin SL. Cleland JG, et al. Lancet. 2007 Sep 29;370(9593):1103-4. doi: 10.1016/S0140-6736(07)61488-3. Lancet. 2007. PMID: 17905146 No abstract available.
Cardiovascular safety of rosiglitazone.
Krall RL. Krall RL. Lancet. 2007 Jun 16;369(9578):1995-1996. doi: 10.1016/S0140-6736(07)60824-1. Lancet. 2007. PMID: 17574083 No abstract available.
The rosiglitazone meta-analysis.
McCullough PA, Lepor NE. McCullough PA, et al. Rev Cardiovasc Med. 2007 Spring;8(2):123-6. Rev Cardiovasc Med. 2007. PMID: 17603430 Review. No abstract available.
[Treatment of patients with type 2 diabetes mellitus with pioglitazone. A survey of a Cochrane review].
Madsbad S. Madsbad S. Ugeskr Laeger. 2007 Nov 19;169(47):4054-7. Ugeskr Laeger. 2007. PMID: 18078659 Review. Danish. No abstract available.

See all similar articles

Cited by

Randomized clinical trial of quick-release bromocriptine among patients with type 2 diabetes on overall safety and cardiovascular outcomes.
Gaziano JM, Cincotta AH, O'Connor CM, Ezrokhi M, Rutty D, Ma ZJ, Scranton RE. Gaziano JM, et al. Diabetes Care. 2010 Jul;33(7):1503-8. doi: 10.2337/dc09-2009. Epub 2010 Mar 23. Diabetes Care. 2010. PMID: 20332352 Free PMC article. Clinical Trial.
Rapid identification of myocardial infarction risk associated with diabetes medications using electronic medical records.
Brownstein JS, Murphy SN, Goldfine AB, Grant RW, Sordo M, Gainer V, Colecchi JA, Dubey A, Nathan DM, Glaser JP, Kohane IS. Brownstein JS, et al. Diabetes Care. 2010 Mar;33(3):526-31. doi: 10.2337/dc09-1506. Epub 2009 Dec 15. Diabetes Care. 2010. PMID: 20009093 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information